OUI Therapeutics Inc.
New Haven, CT
- UEI
- U4K6RELD5F16
- CAGE
- 850C8
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- ouitherapeutics.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ksana Health Inc. | Eugene, OR | 513210 Software Publishers |
| Virtually Better Inc. | Decatur, GA | 541511 Custom Computer Programming Services |
| Mountainpass Technology LLC | Chevy Chase, MD | 541511 Custom Computer Programming Services |
| Talkspace LLC | NY | 621330 Offices of Mental Health Practitioners (except Physicians) |
| Doxy.me Inc. | Charleston, SC | 517121 Telecommunications Resellers |
About the company
OUI Therapeutics Inc. is a for-profit corporate entity based in New Haven, Connecticut, registered in SAM.gov since 2018, that specializes in developing digital therapeutic mobile applications targeting mental health conditions. The company focuses on creating innovative digital interventions for complex mental health challenges, with a particular emphasis on developing technology-based solutions for conditions like post-traumatic stress disorder (PTSD), suicide prevention, binge eating, and obesity. Through its technological approach, OUI Therapeutics aims to provide accessible, scalable mental health interventions that can overcome traditional barriers to treatment such as cost, time constraints, clinician availability, and perceived stigma.
The company has consistently secured federal grant awards from the National Institute of Mental Health (NIMH) to develop and evaluate digital therapeutic applications addressing critical mental health needs. Its primary grant-funded projects include OTX-601 for PTSD treatment, OTX-401 for binge eating and obesity intervention, EYST for suicide prevention among adolescents, and AVIVA, a digital therapeutic targeting suicide prevention for adults and youth. These projects typically follow a phased approach, beginning with initial development and feasibility testing in Phase I, and progressing to larger randomized controlled trials in Phase II. Each project aims to create mobile app-based interventions that can be broadly implemented to enhance mental health treatment accessibility, with a focus on developing scalable, evidence-based digital solutions that can potentially reduce healthcare costs and improve patient outcomes across various mental health domains.
Quick answers
Is OUI Therapeutics Inc. registered in SAM.gov?
Yes. OUI Therapeutics Inc.'s SAM.gov registration is active through December 2, 2026.
What is OUI Therapeutics Inc.'s CAGE code?
OUI Therapeutics Inc.'s CAGE code is 850C8, and its Unique Entity ID (UEI) is U4K6RELD5F16.
What is OUI Therapeutics Inc.'s most recent federal award?
OUI Therapeutics Inc.'s most recent federal grant award is Development and evaluation of a novel digital therapeutic for adults with post-traumatic stress disorder (R44MH136888), from National Institute of Mental Health (NIH), on June 5, 2024.
On GovTribe
See OUI Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors